Cargando…
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial
BACKGROUND: Patients with established coronary artery disease or peripheral artery disease often have diabetes mellitus. These patients are at high risk of future vascular events. METHODS: In a prespecified analysis of the COMPASS trial (Cardiovascular Outcomes for People Using Anticoagulation Strat...
Autores principales: | Bhatt, Deepak L., Eikelboom, John W., Connolly, Stuart J., Steg, P. Gabriel, Anand, Sonia S., Verma, Subodh, Branch, Kelley R.H., Probstfield, Jeffrey, Bosch, Jackie, Shestakovska, Olga, Szarek, Michael, Maggioni, Aldo Pietro, Widimský, Petr, Avezum, Alvaro, Diaz, Rafael, Lewis, Basil S., Berkowitz, Scott D., Fox, Keith A.A., Ryden, Lars, Yusuf, Salim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314494/ https://www.ncbi.nlm.nih.gov/pubmed/32223318 http://dx.doi.org/10.1161/CIRCULATIONAHA.120.046448 |
Ejemplares similares
-
Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial
por: Branch, Kelley R., et al.
Publicado: (2019) -
Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events: A Secondary Analysis of the COMPASS Trial
por: Gaba, Prakriti, et al.
Publicado: (2022) -
Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease
por: Dagenais, Gilles R, et al.
Publicado: (2021) -
The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum
por: McCarthy, Cian P, et al.
Publicado: (2017) -
Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
por: Brunetti, Natale Daniele, et al.
Publicado: (2019)